CLASS III ONGOING Device recall · Reported 6 Nov 2024 · FDA Enforcement Report

17-OH Progesterone Elisa 96 well kit- An enzyme immunoassay recalled

DRG International is recalling 17-OH Progesterone Elisa 96 well kit- An enzyme immunoassay for the quantitative in vitro, distributed in Arizona, California, Georgia, New Hampshire. The recall was initiated on 13 Sep 2024 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot Code: 04048474012927 (DRG Instruments GmbH) lots: 22K024 and 22K034
Quantity recalled504 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0258-2025
FDA event ID
95429
Recalling firm
DRG International, Springfield, NJ
Classification
Class III
Status
Ongoing
Recall initiated
13 Sep 2024
FDA classified
29 Oct 2024
Reported
6 Nov 2024
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

13 Sep 2024Recall initiated by company
29 Oct 2024Classified by FDA+46 days
6 Nov 2024Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnostic measurement of 17-OH Progesterone (17-OHP) in serum or plasma Model/Catalog Number: EIA-1292

Where it was distributed

AZ, CA, NH Foreign: Austria Belgium Georgia Germany Greece India Irak Italy Netherlands Poland Romania Russia Singapore Spain Tunesia Vietnam

ArizonaCaliforniaGeorgiaNew Hampshire

Questions about this recall

Is 17-OH Progesterone Elisa 96 well kit- An enzyme immunoassay for the quantitative in vitro recalled?

Yes. DRG International recalled 17-OH Progesterone Elisa 96 well kit- An enzyme immunoassay for the quantitative in vitro on 13 Sep 2024. The recall is Class III and its status is Ongoing. Recall number Z-0258-2025.

Why was it recalled?

The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.

Which lots are affected?

Lot Code: 04048474012927 (DRG Instruments GmbH) lots: 22K024 and 22K034

Where was it sold?

AZ, CA, NH Foreign: Austria Belgium Georgia Germany Greece India Irak Italy Netherlands Poland Romania Russia Singapore Spain Tunesia Vietnam

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from DRG International

All 6

Other Test Kits & Diagnostics recalls

All 2,656